Jody Tanabe
Overview
Explore the profile of Jody Tanabe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1600
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weisbrod L, Schmidt A, Tanabe J, Sakai J, Ojemann S, Pawlowski J, et al.
J Neuropsychiatry Clin Neurosci
. 2025 Feb;
:appineuropsych20240142.
PMID: 39962978
Substance use disorders, including methamphetamine use disorder, are prevalent, causing extensive morbidity and death. Despite advances in evidence-based treatments for methamphetamine use disorder, many patients do not respond to these...
2.
3.
Vachha B, Kumar V, Pillai J, Shimony J, Tanabe J, Sair H
AJR Am J Roentgenol
. 2024 Dec;
PMID: 39660823
Resting-state functional MRI (rs-fMRI), a promising method for interrogating different brain functional networks from a single MRI acquisition, is increasingly utilized in clinical presurgical and other pretherapeutic brain mapping. However,...
4.
Shah B, Tanabe J, Jordan J, Kern D, Harward S, Feltrin F, et al.
AJNR Am J Neuroradiol
. 2024 Nov;
46(1):2-10.
PMID: 39572202
Transcranial focused ultrasound (FUS) is a versatile, MR-guided, incisionless intervention with diagnostic and therapeutic applications for neurologic and psychiatric diseases. It is currently FDA-approved as a thermoablative treatment of essential...
5.
Tanabe J, Lim M, Dash S, Pattee J, Steach B, Pressman P, et al.
AJNR Am J Neuroradiol
. 2024 Oct;
45(11):1737-1744.
PMID: 39362700
Background And Purpose: Brain atrophy occurs in the late stage of dementia, yet structural MRI is widely used in the work-up. Atrophy patterns can suggest a diagnosis of Alzheimer disease...
6.
Cogswell P, Andrews T, Barakos J, Barkhof F, Bash S, Benayoun M, et al.
AJNR Am J Neuroradiol
. 2024 Aug;
46(1):24-32.
PMID: 39179297
With full FDA approval and Centers for Medicare & Medicaid Services coverage of lecanemab and donanemab, a growing number of practices are offering anti-amyloid immunotherapy to appropriate patients with cognitive...
7.
Sakai J, Tanabe J, Battula S, Zipperly M, Mikulich-Gilbertson S, Kern D, et al.
Front Psychiatry
. 2024 Jul;
15:1435109.
PMID: 39071229
Substance use disorders are prevalent, causing extensive morbidity and mortality worldwide. Evidence-based treatments are of low to moderate effect size. Growth in the neurobiological understanding of addiction (e.g., craving) along...
8.
Wintermark M, Allen J, Bhala R, Doshi A, Mukherjee S, Nickerson J, et al.
AJNR Am J Neuroradiol
. 2024 Apr;
45(11):1621-1623.
PMID: 38684321
The ASNR Neuroradiology Division Chief Working Group's 2023 survey, with responses from 62 division chiefs, provides insights into turnaround times, faculty recruitment, moonlighting opportunities, and academic funds. In emergency cases,...
9.
Jiang B, Ozkara B, Zhu G, Boothroyd D, Allen J, Barboriak D, et al.
AJNR Am J Neuroradiol
. 2024 Apr;
45(9):1276-1283.
PMID: 38663992
Background And Purpose: Artificial intelligence models in radiology are frequently developed and validated using data sets from a single institution and are rarely tested on independent, external data sets, raising...
10.
Sloan M, Sanches M, Tanabe J, Gowin J
Sci Rep
. 2023 Dec;
13(1):21977.
PMID: 38081908
Delay discounting is a tendency to devalue delayed rewards compared to immediate rewards. Evidence suggests that steeper delay discounting is associated with psychiatric disorders across diagnostic categories, but it is...